Peresolimab Found to Be Efficacious for Rheumatoid Arthritis

THURSDAY, May 18, 2023 -- Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according...